Explore drug properties, targets, and indications with answers grounded in DrugCentral.
Powered by DrugCentral + retrieval-augmented AIAsk in your own words. Each question is answered independently.
Select a question to fill the editor, then ask it or make it your own.
Your answer will appear here. Open linked drug cards in a new tab to explore the source details.
Ask DrugCentral helps you explore drug properties, biological targets, and indications using natural language. Sample questions offer starting points, and linked drug cards let you check the underlying records.
Each request is independent; previous questions are not sent as conversation history. You can edit a sample before submitting, retry a failed request, or switch back to normal search. Drug links open in a new tab so your question and answer stay available.
Answers may contain mistakes or omit information. Verify details against DrugCentral records and original sources.
AI can make mistakes. Verify answers against the original sources before relying on them.
| Stem definition | Drug id | CAS RN |
|---|---|---|
| NO2 - derivatives | 4502 | 7761-88-8 |
| Molecule | Description |
|---|---|
|
Synonyms:
|
A silver salt with powerful germicidal activity. It has been used topically to prevent OPHTHALMIA NEONATORUM.
|
None
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Product dose omission issue | 34.97 | 15.63 | 54 | 4098 | 291633 | 90332662 |
| Stoma site erythema | 25.46 | 15.63 | 7 | 4145 | 1489 | 90622806 |
| Stoma site discharge | 23.49 | 15.63 | 7 | 4145 | 1982 | 90622313 |
| Fibroma | 23.44 | 15.63 | 6 | 4146 | 970 | 90623325 |
| On and off phenomenon | 21.79 | 15.63 | 7 | 4145 | 2536 | 90621759 |
| Stoma site haemorrhage | 21.57 | 15.63 | 6 | 4146 | 1332 | 90622963 |
| Diarrhoea | 21.24 | 15.63 | 92 | 4060 | 939098 | 89685197 |
| Ventricular septal defect | 20.05 | 15.63 | 8 | 4144 | 5399 | 90618896 |
| Stoma site hypergranulation | 17.44 | 15.63 | 4 | 4148 | 409 | 90623886 |
| Stoma site pain | 16.79 | 15.63 | 5 | 4147 | 1412 | 90622883 |
| Therapeutic reaction time decreased | 15.64 | 15.63 | 6 | 4146 | 3652 | 90620643 |
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Exposure during pregnancy | 46.56 | 20.28 | 17 | 2057 | 8531 | 42610730 |
| Alcohol abuse | 33.47 | 20.28 | 11 | 2063 | 4038 | 42615223 |
| Testicular haemorrhage | 24.97 | 20.28 | 5 | 2069 | 252 | 42619009 |
| Stoma site irritation | 20.67 | 20.28 | 4 | 2070 | 169 | 42619092 |
| Groin infection | 20.49 | 20.28 | 5 | 2069 | 628 | 42618633 |
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Product dose omission issue | 37.00 | 16.88 | 57 | 4779 | 321725 | 110262738 |
| Alcohol abuse | 32.49 | 16.88 | 11 | 4825 | 4918 | 110579545 |
| Therapeutic reaction time decreased | 31.75 | 16.88 | 11 | 4825 | 5268 | 110579195 |
| Diarrhoea | 28.12 | 16.88 | 111 | 4725 | 1139394 | 109445069 |
| Testicular haemorrhage | 25.58 | 16.88 | 5 | 4831 | 248 | 110584215 |
| Drug dependence | 20.07 | 16.88 | 17 | 4819 | 50003 | 110534460 |
| Penile haemorrhage | 19.22 | 16.88 | 5 | 4831 | 903 | 110583560 |
| Groin infection | 18.41 | 16.88 | 5 | 4831 | 1065 | 110583398 |
None
| Source | Code | Description |
|---|---|---|
| ATC | D08AL01 | DERMATOLOGICALS ANTISEPTICS AND DISINFECTANTS ANTISEPTICS AND DISINFECTANTS Silver compounds |
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000891 | Anti-Infective Agents, Local |
| CHEBI has role | CHEBI:33282 | antibacterial agent |
| CHEBI has role | CHEBI:231911 | renoprotective agent |
None
None
None
None
None
None
None
| ID | Source |
|---|---|
| D01730 | KEGG_DRUG |
| 4017465 | VUID |
| N0000145853 | NUI |
| 4017465 | VANDF |
| CHEBI:32130 | CHEBI |
| CHEMBL177367 | ChEMBL_ID |
| DB11080 | DRUGBANK_ID |
| 95IT3W8JZE | UNII |
| 9789 | RXNORM |
| 11553 | MMSL |
| 1644 | MMSL |
| 5461 | MMSL |
| d01212 | MMSL |
| 003132 | NDDF |
| 255985001 | SNOMEDCT_US |
| 35476001 | SNOMEDCT_US |
| 373483000 | SNOMEDCT_US |
| 411331002 | SNOMEDCT_US |
| C0037129 | UMLSCUI |
| D012835 | MESH_DESCRIPTOR_UI |
| 24470 | PUBCHEM_CID |
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| Silver Nitrate | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0093-9614 | SOLUTION | 0.01 g | TOPICAL | unapproved drug other | 2 sections |
| STYPTSTIX | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0404-1000 | STICK | 38.21 mg | TOPICAL | unapproved drug other | 8 sections |
| GRAFCOAPPLICATOR 15 CM | HUMAN PRESCRIPTION DRUG LABEL | 2 | 12165-100 | STICK | 38.21 mg | TOPICAL | unapproved drug other | 7 sections |
| GRAFCOAPPLICATOR 30 CM | HUMAN PRESCRIPTION DRUG LABEL | 2 | 12165-200 | STICK | 52.45 mg | TOPICAL | unapproved drug other | 8 sections |
| GRAFCOAPPLICATOR 45 CM | HUMAN PRESCRIPTION DRUG LABEL | 2 | 12165-300 | STICK | 73.43 mg | TOPICAL | unapproved drug other | 8 sections |
| Silver Nitrate Applicators | HUMAN PRESCRIPTION DRUG LABEL | 2 | 12870-0001 | STICK | 75 mg | TOPICAL | unapproved drug other | 14 sections |
| Silver Nitrate Applicators | HUMAN PRESCRIPTION DRUG LABEL | 2 | 12870-0001 | STICK | 75 mg | TOPICAL | unapproved drug other | 14 sections |
| Vet one | HUMAN PRESCRIPTION DRUG LABEL | 2 | 13985-706 | STICK | 38.21 mg | Topical | unapproved drug other | 8 sections |
| GRAFCO SILVER NITRATE (75% SILVER NITRATE, 25% POTASSIUM NITRATE) | HUMAN PRESCRIPTION DRUG LABEL | 2 | 51662-1611 | STICK | 38.21 mg | TOPICAL | unapproved drug other | 8 sections |
| Silver Nitrate | HUMAN PRESCRIPTION DRUG LABEL | 1 | 64950-378 | SOLUTION | 0.01 g | TOPICAL | Unapproved drug other | 6 sections |
| Avoca Flexible Caustic Applicator | HUMAN PRESCRIPTION DRUG LABEL | 1 | 65875-101 | STICK | 30 mg | TOPICAL | unapproved drug other | 6 sections |
| Repara Silver NitrateApplicators | HUMAN PRESCRIPTION DRUG LABEL | 2 | 68345-100 | STICK | 75 mg | TOPICAL | unapproved drug other | 9 sections |
| SILVER NITRATE POTASSIUM NITRATE | HUMAN PRESCRIPTION DRUG LABEL | 2 | 68599-6302 | STICK | 25 mg | TOPICAL | unapproved drug other | 6 sections |
| Swabs | HUMAN PRESCRIPTION DRUG LABEL | 2 | 68599-6303 | SWAB | 75 g | TOPICAL | unapproved drug other | 6 sections |
| ANTI-BACTERIAL SLIME | HUMAN OTC DRUG LABEL | 1 | 78048-014 | GEL | 0.01 g | TOPICAL | unapproved drug other | 11 sections |
| ANTIBACTERIAL FEMININE WIPE | HUMAN OTC DRUG LABEL | 1 | 84938-004 | CLOTH | 0.01 g | TOPICAL | OTC Monograph Drug | 9 sections |